Brendan Saloner ( bsaloner@jhu. edu ) is an associate professor in the Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, in Baltimore, Maryland.
Johanna Catherine Maclean is an associate professor of economics at Temple University, in Philadelphia, Pennsylvania, and a research associate at the National Bureau of Economic Research in Cambridge, Massachusetts.
Health Aff (Millwood). 2020 Mar;39(3):453-461. doi: 10.1377/hlthaff.2019.01428.
The Affordable Care Act's Medicaid expansion provided insurance coverage to many low-income adults with substance use disorders, but it is unclear whether this led to more people receiving treatment. We used the Treatment Episode Data Set and a difference-in-differences approach to compare annual rates of specialty treatment admissions in expansion versus nonexpansion states in the period 2010-17. We found that admissions to treatment steadily increased in the four years after Medicaid expansion, with 36 percent more people entering treatment by the fourth expansion year in expansion states compared to nonexpansion states. Changes were largest for people entering intensive outpatient programs and those seeking medication treatment for opioid use disorder. The share of admissions paid for by Medicaid increased 23 percentage points in expansion states compared to nonexpansion states, largely displacing treatment paid for by state and local governments. The gradual increase in specialty substance use disorder treatment admissions after Medicaid expansion may reflect improving capacity and access to care.
平价医疗法案的医疗补助扩展计划为许多患有药物滥用障碍的低收入成年人提供了保险覆盖,但尚不清楚这是否导致更多人接受治疗。我们使用治疗事件数据集和差异中的差异方法,比较了 2010 年至 2017 年期间,在扩张和非扩张州接受专科治疗入院的年度比率。我们发现,在医疗补助扩张后的四年中,治疗入院率稳步上升,扩张州在第四年扩张年进入治疗的人数比非扩张州多 36%。对于进入强化门诊计划和寻求阿片类药物使用障碍药物治疗的人来说,变化最大。在扩张州,由医疗补助支付的入院人数比非扩张州增加了 23 个百分点,这在很大程度上取代了由州和地方政府支付的治疗费用。医疗补助扩张后,专科药物滥用障碍治疗入院人数的逐渐增加可能反映了治疗能力和获得治疗的改善。